Filing Flows › Inovio Pharmaceuticals (INO) › Q1 2025 › vs Q4 2024
Inovio Pharmaceuticals (INO) Q1 2025 vs Q4 2024 (quarter over quarter)
Inovio Pharmaceuticals's revenue fell $52K (-44%) from $117K in Q4 2024 to $65K in Q1 2025.
Inovio Pharmaceuticals, Q1 2025: revenue $65K, net loss $19.7M, operating cash flow −$26.9M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $65K | $117K | −$52K | -44% |
| Other income, net | $5.4M | $988K | $4.4M | +442% |
| Net loss | $19.7M | $19.4M | $313K | +2% |
| Costs & expenses | $25.1M | $20.5M | $4.6M | +23% |
| Operating costs | $25.1M | $20.5M | $4.6M | +23% |
| Research & development | $16.1M | $12.9M | $3.2M | +25% |
| General & admin | $9.0M | $7.6M | $1.4M | +19% |
| Operating cash sources | $28.6M | $21.4M | $7.2M | +34% |
| Depreciation | $371K | $417K | −$45K | -11% |
| Share-based compensation | $1.4M | $1.3M | $84K | +6% |
| Cash used in operations | $26.9M | $19.7M | $7.2M | +37% |
| Net loss absorbed | $19.7M | $19.4M | $313K | +2% |
| Working capital & other | $9.0M | $2.0M | $6.9M | +344% |
Questions
How much did Inovio Pharmaceuticals's revenue grow quarter over quarter in Q1 2025?
Inovio Pharmaceuticals's revenue fell $52K (-44%) from $117K in Q4 2024 to $65K in Q1 2025.